129 related articles for article (PubMed ID: 2343159)
61. Predictors of adherence to follow-up recommendations after an abnormal Pap smear among underserved inner-city women.
Miller SM; Tagai EK; Wen KY; Lee M; Hui SA; Kurtz D; Scarpato J; Hernandez E
Patient Educ Couns; 2017 Jul; 100(7):1353-1359. PubMed ID: 28190541
[TBL] [Abstract][Full Text] [Related]
62. Case management intervention in cervical cancer prevention: the Boston REACH coalition women's health demonstration project.
Clark CR; Baril N; Hall A; Kunicki M; Johnson N; Soukup J; Lipsitz S; Bigby J
Prog Community Health Partnersh; 2011; 5(3):235-47. PubMed ID: 22080772
[TBL] [Abstract][Full Text] [Related]
63. Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Harlem Study Team.
Mandelblatt J; Traxler M; Lakin P; Kanetsky P; Thomas L; Chauhan P; Matseoane S; Ramsey E
Am J Prev Med; 1993; 9(3):133-8. PubMed ID: 8347363
[TBL] [Abstract][Full Text] [Related]
64. How can young women be encouraged to attend cervical cancer screening? Suggestions from face-to-face and internet focus group discussions with 30-year-old women in Stockholm, Sweden.
Blomberg K; Tishelman C; Ternestedt BM; Törnberg S; Levál A; Widmark C
Acta Oncol; 2011 Jan; 50(1):112-20. PubMed ID: 21091087
[TBL] [Abstract][Full Text] [Related]
65. Nonadherence to follow-up treatment of an abnormal Pap smear: a case study.
Rajaram SS
Cancer Nurs; 1998 Oct; 21(5):342-8. PubMed ID: 9775484
[TBL] [Abstract][Full Text] [Related]
66. Tailored telephone counseling to improve adherence to follow-up regimens after an abnormal pap smear among minority, underserved women.
Miller SM; Hui SK; Wen KY; Scarpato J; Zhu F; Buzaglo J; Hernandez EE
Patient Educ Couns; 2013 Dec; 93(3):488-95. PubMed ID: 24007767
[TBL] [Abstract][Full Text] [Related]
67. Management of the patient with an abnormal Papanicolaou smear.
Chirenje ZM
Cent Afr J Med; 1994 May; 40(5):131-4. PubMed ID: 7954725
[TBL] [Abstract][Full Text] [Related]
68. Structural and sociocultural factors associated with cervical cancer screening among HIV-infected African American women in Alabama.
Williams M; Moneyham L; Kempf MC; Chamot E; Scarinci I
AIDS Patient Care STDS; 2015 Jan; 29(1):13-9. PubMed ID: 25514125
[TBL] [Abstract][Full Text] [Related]
69. How reminders given to patients and physicians affected pap smear use in a health maintenance organization: results of a randomized controlled trial.
Burack RC; Gimotty PA; George J; McBride S; Moncrease A; Simon MS; Dews P; Coombs J
Cancer; 1998 Jun; 82(12):2391-400. PubMed ID: 9635532
[TBL] [Abstract][Full Text] [Related]
70. Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial.
Broberg G; Jonasson JM; Ellis J; Gyrd-Hansen D; Anjemark B; Glantz A; Söderberg L; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2013 Jul; 133(1):164-71. PubMed ID: 23233356
[TBL] [Abstract][Full Text] [Related]
71. Compliance behavior in women with abnormal Pap smears. Developing and testing a decision model.
Paskett ED; Carter WB; Chu J; White E
Med Care; 1990 Jul; 28(7):643-56. PubMed ID: 2366603
[TBL] [Abstract][Full Text] [Related]
72. Management and follow-up of abnormal Papanicolaou tests.
Gingrich PM
J Am Med Womens Assoc (1972); 2004; 59(1):54-60. PubMed ID: 14768988
[TBL] [Abstract][Full Text] [Related]
73. Cervical cytology screening: a comparison of two call systems.
Wilson A; Leeming A
Br Med J (Clin Res Ed); 1987 Jul; 295(6591):181-2. PubMed ID: 3115368
[No Abstract] [Full Text] [Related]
74. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
Mayeaux EJ; Harper MB; Abreo F; Pope JB; Phillips GS
J Fam Pract; 1995 Jan; 40(1):57-62. PubMed ID: 7807039
[TBL] [Abstract][Full Text] [Related]
75. A 6-year experience with Pap smears in an urban adolescent practice: the scope and burden of abnormalities.
Soren K; Kharbanda EO; Chen S; Westhoff C
J Pediatr Adolesc Gynecol; 2009 Aug; 22(4):217-22. PubMed ID: 19646666
[TBL] [Abstract][Full Text] [Related]
76. Accuracy of the Papanicolaou test in the detection of high-grade cervical lesions.
Repše-Fokter A
Int J Gynaecol Obstet; 2011 Jan; 112(1):65-6. PubMed ID: 21056413
[No Abstract] [Full Text] [Related]
77. Effect of health education about cervical cancer and papanicolaou testing on the behavior, knowledge, and beliefs of Turkish women.
Bebis H; Reis N; Yavan T; Bayrak D; Unal A; Bodur S
Int J Gynecol Cancer; 2012 Oct; 22(8):1407-12. PubMed ID: 22932261
[TBL] [Abstract][Full Text] [Related]
78. Colposcopy in women with a normal Papanicolaou smear.
Peedicayil A; Regi A; Mathai M; Jasper P
Natl Med J India; 1994; 7(5):208-9. PubMed ID: 7827598
[TBL] [Abstract][Full Text] [Related]
79. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
[TBL] [Abstract][Full Text] [Related]
80. Patient-provider communication with HIV-positive women about abnormal Pap test results.
Wigfall LT; Bynum SA; Friedman DB; Brandt HM; Richter DL; Glover SH; Hébert JR
Women Health; 2017 Jan; 57(1):19-39. PubMed ID: 26886433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
